rs141579198
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP6
The NM_001849.4(COL6A2):c.2935G>A(p.Asp979Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00017 in 1,606,996 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2935G>A | p.Asp979Asn | missense_variant | Exon 28 of 28 | ENST00000300527.9 | NP_001840.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152224Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000193 AC: 47AN: 244150Hom.: 0 AF XY: 0.000195 AC XY: 26AN XY: 133064
GnomAD4 exome AF: 0.000175 AC: 255AN: 1454654Hom.: 0 Cov.: 34 AF XY: 0.000178 AC XY: 129AN XY: 723020
GnomAD4 genome AF: 0.000118 AC: 18AN: 152342Hom.: 0 Cov.: 34 AF XY: 0.0000940 AC XY: 7AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:5
Seen in an individual with limb-girdle muscular dystrophy in published literature (Nallamilli et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: Junkerov_2018, 30564623) -
- -
The COL6A2 p.Asp979Asn variant was not identified in the literature but was identified in dbSNP (ID: rs141579198) and ClinVar (classified as uncertain significance by Invitae and EGL Genetics). The variant was identified in control databases in 51 of 275508 chromosomes at a frequency of 0.0001851 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 41 of 124892 chromosomes (freq: 0.000328), European (Finnish) in 4 of 22908 chromosomes (freq: 0.000175), Latino in 5 of 35300 chromosomes (freq: 0.000142) and Other in 1 of 7124 chromosomes (freq: 0.00014), but was not observed in the African, Ashkenazi Jewish, East Asian, or South Asian populations. The p.Asp979 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
COL6A2: PM2 -
Bethlem myopathy 1A Benign:1
- -
Collagen 6-related myopathy Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at